中国畜牧兽医 ›› 2024, Vol. 51 ›› Issue (2): 799-808.doi: 10.16431/j.cnki.1671-7236.2024.02.036

• 基础兽医 • 上一篇    下一篇

牡荆水提物对蓖麻油腹泻小鼠的治疗作用研究

唐兴刚1, 罗胜军1, 袁明贵1, 田雅1, 舒柄垚1, 杨希2, 李跃龙3, 向蓉1,4   

  1. 1. 广东省农业科学院动物卫生研究所, 农业农村部兽用药物与诊断技术广东科学观测实验站, 广东省畜禽疫病防治研究重点实验室, 广东省中兽药工程技术研究中心, 广州 510640;
    2. 广东省农业科学院动物科学研究所, 广州 510640;
    3. 广东省农产品质量安全中心, 广州 510230;
    4. 岭南现代农业科学与技术广东省实验室茂名分中心, 茂名 525000
  • 收稿日期:2023-07-18 出版日期:2024-02-05 发布日期:2024-01-29
  • 作者简介:唐兴刚,E-mail:tangxingang@gdaas.cn。

Study on Therapeutic Effect of Aqueous Extract of Vitex negundo L.var.cannabifolia (Sieb.et Zucc.) Hand.-Mazz.on Castor Oil Induced Diarrhea in Mice

TANG Xinggang1, LUO Shengjun1, YUAN Minggui1, TIAN Ya1, SHU Bingyao1, YANG Xi2, LI Yuelong3, XIANG Rong1,4   

  1. 1. Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, Key Laboratory of Livestock Disease Prevention of Guangdong Province, Chinese Traditional Medicine Engineering Technology Research Center of Guangdong Province, Guangzhou 510640, China;
    2. Institute of Animal Science, Guangdong Academy of Agricultural Sciences, Guangzhou 510640, China;
    3. Center of Agriculture Food Quality Safety of Guangdong Province, Guangzhou 510230, China;
    4. Maoming Branch, Guangdong Laboratory for Lingnan Modern Agriculture, Maoming 525000, China
  • Received:2023-07-18 Online:2024-02-05 Published:2024-01-29
  • Contact: 广东省农业科学院协同创新中心(XTXM202202);广东省科技计划项目(2021B1212050021、2020B0202080004);茂名实验室科研启动项目(2021TDQD002) E-mail:gdliyuelong@163.com;23753842@qq.com

摘要: 【目的】研究牡荆水提物对蓖麻油致小鼠腹泻的治疗作用,评价牡荆提取物的抗腹泻功效,为开发新型天然药物或植物提取物饲料添加剂提供理论依据。【方法】选取48只18~22 g SPF级昆明小鼠,随机分为6组:对照组、模型组、洛哌丁胺组及牡荆水提物高、中、低剂量组,每组8只,雌雄各半。牡荆水提物高、中、低剂量组小鼠灌胃16、8、4 g/kg BW牡荆水提物,对照组和模型组小鼠灌胃等剂量的生理盐水,洛哌丁胺组小鼠灌胃5 mg/kg BW洛哌丁胺,连续灌胃5 d。第5天给药后0.5 h,模型组、洛哌丁胺组及牡荆水提物高、中、低剂量组小鼠灌胃0.5 mL蓖麻油灌胃造模,对照组灌胃等量生理盐水。造模后的小鼠单笼单只饲喂。连续4 h观察小鼠腹泻情况,4 h后小鼠采血并断颈处死,每组随机取4只小鼠的肝脏、小肠各两份,一份制作组织切片;另一份用以提取RNA,检测空肠通道蛋白和肝脏急性期蛋白mRNA表达情况。【结果】模型组小鼠腹泻评分和腹泻指数均极显著高于对照组(P<0.01),说明蓖麻油腹泻模型造模成功。与模型组相比,洛哌丁胺组和牡荆水提物高剂量组小鼠腹泻评分和腹泻指数均极显著或显著降低(P<0.01;P<0.05);牡荆水提物高剂量组小鼠血清中白细胞介素1β(IL-1β)、IL-6、IL-10含量均显著或极显著降低(P<0.05;P<0.01)。肝脏组织病理结果显示,牡荆水提物高、中、低剂量组小鼠肝索结构清晰,肝细胞排列紧密,仅少量肝细胞轻度肿胀,并伴少量炎性细胞浸润。肠道组织病理结果显示,牡荆水提物高、中、低剂量组小鼠空肠黏膜层、肌层、浆膜层均清晰可见,黏膜层绒毛上皮内见大量空泡,但均未见明显坏死或炎症反应。与模型组相比,牡荆水提物高剂量组小鼠空肠中NHE8、NHE3、AQP3、AQP4表达量均无显著差异(P>0.05),NHE2表达量显著降低(P<0.05),急性期蛋白TRF和CRP表达量均显著降低(P<0.05)。【结论】牡荆水提物对蓖麻油导致的小鼠腹泻模型具有较好的治疗作用,对肝脏和小肠黏膜具有一定的保护作用,作用机制可能与其降低血清中IL-6、IL-10含量,以及在一定程度上降低NHE2表达、抑制TRF和CRP的表达有关。

关键词: 牡荆水提物; 腹泻; 炎症因子; 通道蛋白; 急性期蛋白

Abstract: 【Objective】 This study was aimed to explore the therapeutic effect of aqueous extract of Vitex negundo L.var.cannabifolia (Sieb.et Zucc.) Hand.-Mazz.on diarrhea induced by castor oil in mice, evaluate its anti diarrhea effect, and provide theoretical basis for the development of new natural drugs or plant extract feed additives.【Method】 48 SPF KM mice weighing 18-22 g were selected.The mice were randomly divided into six groups which including control, model, loperamide, Vitex negundo L.var.cannabifolia(Sieb.et Zucc.)Hand.- Mazz.aqueous extract high, medium and low dose groups, 8 in each group, half male and half female.Mice were gavaged with 16, 8 and 4 g/kg BW in high, medium and low dose groups, respectively, equal doses of saline were gavaged in control and model groups, and 5 mg/kg BW loperamide were practiced in loperamide group.The mice were gavaged for 5 d.0.5 h after administration on the 5th day, mice in model, loperamide, and the high, medium and low dose groups were gavaged with 0.5 mL castor oil for modeling, and mice in control group were gavaged with the same amount of saline.The mice were caged one by one after modeling and were observed the diarrhea for 4 h.After 4 h, blood samples were collected and mice were executed by cervical dislocation, two copies of liver and small intestine were randomly taken from 4 mice in each group, and one copy was for tissue section, the other copy was for RNA extraction to detect mRNA expression of jejunal channel protein and acute phase protein of liver.【Result】 The diarrhea score and diarrhea index of mice in model group were extremely significantly higher than those in control group (P<0.01), indicating that the castor oil diarrhea model was manufactured successfully.The diarrhea score and diarrhea index of mice in loperamide and high dose groups were extremely significantly or significantly lower than those in model group (P<0.01 or P<0.05).The concentration of interleukin-1β (IL-1β), IL-6 and IL-10 in serum of mice in high dose group were significantly or extremely significantly lower than those in model group (P<0.05 or P<0.01).The histopathological results of liver showed that the hepatic cords were clear and the hepatocytes were closely arranged in high, medium and low dose groups, and only a few hepatocytes were mildly swollen and infiltrated with a few inflammatory cells.The results of the intestine histopathology showed that the mucosal layer, muscle layer and plasma layer of jejunum were clearly visible in high, medium and low dose groups, and a large number of vacuoles were seen in villous epithelium of mucosal layer, but no obvious necrosis or inflammatory reactions were observed.Compared with model group, the expression of NHE8, NHE3, AQP3 and AQP4 of jejunum in mice were not significantly different in high dose group (P>0.05), while the expression of NHE2 was significantly lower (P<0.05), and the expression of the acute phase proteins TRF and CRP were significantly lower (P<0.05).【Conclusion】 The therapeutic effect of aqueous extract of Vitex negundo L.var.cannabifolia (Sieb.et Zucc.) Hand.-Mazz.on castor oil-induced diarrhea model in mice was good, and could protect liver and small intestine mucosa.The mechanism might be related to the reduction of IL-6 and IL-10 levels in serum and decreasing NHE2 expression and the inhibition of TRF and CRP expression.

Key words: aqueous extract of Vitex negundo L.var.cannabifolia (Sieb.et Zucc.) Hand.-Mazz.; diarrhea; inflammatory factors; channel proteins; acute phase proteins

中图分类号: